Demant A/S (CPH:DEMANT)
180.90
-0.70 (-0.39%)
At close: Mar 19, 2026
Demant Market Cap
Demant has a market cap or net worth of 38.3 billion as of March 19, 2026. Its market cap has decreased by -30.53% in one year.
Market Cap
38.30B
Enterprise Value
58.03B
Revenue
22.97B
Ranking
n/a
PE Ratio
16.21
Stock Price
180.90
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 38.30B, an increase of 1,707.47%. That is a compound annual growth rate of 10.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 38.30B | -16.45% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.11T |
| Genmab | 105.16B |
| Coloplast | 100.45B |
| ALK-Abelló | 46.53B |
| H. Lundbeck | 36.84B |
| Zealand Pharma | 19.81B |
| Ambu A/S | 18.81B |
| GN Store Nord | 15.32B |